{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:20:11Z","timestamp":1773325211445,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jad.2014.06.006","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T13:03:51Z","timestamp":1402923831000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment"],"prefix":"10.1016","volume":"167","author":[{"given":"Susan","family":"Ball","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Anne","family":"Dellva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah N.","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren B.","family":"Marangell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.jad.2014.06.006_bib1","first-page":"1","article-title":"Practice guideline for the treatment of patients with Major Depressive Disorder (revision)","volume":"157","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2014.06.006_bib2","first-page":"1219","article-title":"APA releases guidelines on treatment of patients with major depressive disorder","volume":"83","author":"Armstrong","year":"2011","journal-title":"Am. Fam. Physician"},{"issue":"11","key":"10.1016\/j.jad.2014.06.006_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/ijcp.12298","article-title":"Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant \u2013 what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?","volume":"67","author":"Citrome","year":"2013","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jad.2014.06.006_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1056-8719(03)00008-X","article-title":"How to correct the QT interval for the effects of heart rate in clinical studies","volume":"48","author":"Davey","year":"2002","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"6","key":"10.1016\/j.jad.2014.06.006_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1755-5949.2010.00217.x","article-title":"The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects","volume":"17","author":"Dell\u05f3Osso","year":"2011","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.jad.2014.06.006_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpsychires.2009.09.013","article-title":"A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression","volume":"44","author":"Dub\u00e9","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"Suppl. 4","key":"10.1016\/j.jad.2014.06.006_bib7","first-page":"S17","article-title":"Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning","volume":"11","author":"Dubini","year":"1997","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2014.06.006_bib8","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"issue":"11","key":"10.1016\/j.jad.2014.06.006_bib9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4088\/JCP.v67n1113","article-title":"A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment","volume":"67","author":"Fava","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2014.06.006_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11530230-000000000-00000","article-title":"Defining and measuring functional recovery from depression","volume":"24","author":"Greer","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2014.06.006_bib11","series-title":"ECDEU Assessment Manual for Psychopharmacology:Revised (DHEW Publ. No. ADM 76-338)","first-page":"218","author":"Guy","year":"1976"},{"issue":"8","key":"10.1016\/j.jad.2014.06.006_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archpsyc.55.8.694","article-title":"A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders","volume":"55","author":"Judd","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl. A 5\u20136","key":"10.1016\/j.jad.2014.06.006_bib13","first-page":"4S","article-title":"Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials","volume":"10","author":"Keefe","year":"2013","journal-title":"Innov. Clin. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.jad.2014.06.006_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-0327(03)00054-5","article-title":"Residual symptoms at remission from depression: impact on long-term outcome","volume":"80","author":"Kennedy","year":"2004","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2014.06.006_bib15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jad.2009.06.043","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorders in adults. Introduction","volume":"117","author":"Kennedy","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2014.06.006_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mpr.340","article-title":"How to assess the clinical impact of treatments on patients, rather than the statistical impact of treatments on measures","volume":"20","author":"Kraemer","year":"2011","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"1\u20133","key":"10.1016\/j.jad.2014.06.006_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jad.2011.06.028","article-title":"Development and validation of a patient-report measure of fatigue associated with depression","volume":"134","author":"Matza","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2014.06.006_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11136-012-0142-6","article-title":"The fatigue associated with depression questionnaire (FAsD): responsiveness and responder definition","volume":"22","author":"Matza","year":"2013","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.jad.2014.06.006_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/da.20505","article-title":"Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder","volume":"26","author":"Mauskopf","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2014.06.006_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"23","key":"10.1016\/j.jad.2014.06.006_bib21","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2013.281422","article-title":"The optimal practice of evidence-based medicine: Incorporating patient preferences into practice guidelines","volume":"310","author":"Montori","year":"2013","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jad.2014.06.006_bib22","series-title":"Depression: The Treatment and Management of Depression in Adults","year":"2009"},{"issue":"6","key":"10.1016\/j.jad.2014.06.006_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jpsychires.2011.03.014","article-title":"A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder","volume":"45","author":"Pangallo","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"Suppl. 11","key":"10.1016\/j.jad.2014.06.006_bib24","first-page":"S316","article-title":"Major depressive disorder: psychosocial impairment and key considerations in functional improvement","volume":"15","author":"Papakostas","year":"2009","journal-title":"Am. J. Manag. Care"},{"issue":"2\u20133","key":"10.1016\/j.jad.2014.06.006_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000115779","article-title":"Timing of clinical improvement in the symptom resolution in the treatment of major depressive disorder","volume":"56","author":"Papakostas","year":"2007","journal-title":"Neuropsychobiology"},{"issue":"6","key":"10.1016\/j.jad.2014.06.006_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0033291700033146","article-title":"Residual symptoms after partial remission: an important outcome in depression","volume":"25","author":"Paykel","year":"1995","journal-title":"Psychol. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.jad.2014.06.006_bib27","first-page":"460","article-title":"Reliability and validity of the fatigue associated with depression questionnaire (FAsD): an interim analysis","volume":"16","author":"Phillips","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jad.2014.06.006_bib28","series-title":"State of the Science: Measurement of Suicidal Adverse Events and the Columbia Suicide Severity Rating Scale","author":"Posner","year":"2007"},{"issue":"5","key":"10.1016\/j.jad.2014.06.006_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.006_bib30","series-title":"The Anxiety Disease","first-page":"151","author":"Sheehan","year":"1983"},{"issue":"Suppl 20","key":"10.1016\/j.jad.2014.06.006_bib31","first-page":"22","article-title":"The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.006_bib32","unstructured":"Suehs, B., Argo, T.R., Bendele, S.D., Crismon, M.L., Trivedi, M.H., Kurian, B., 2008. Texas medication algorithm project procedural manual: major depressive disorder algorithms. Texas Department of State Health Services. \u3008http:\/\/www.pbhcare.org\/pubdocs\/upload\/documents\/TMAP%20Depression%202010.pdf\u3009(accessed 08.05.14.)."},{"issue":"1","key":"10.1016\/j.jad.2014.06.006_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2014.06.006_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/YIC.0b013e3282f948f5","article-title":"The GRID-HAMD: standardization of the Hamilton Depression Rating Scale","volume":"23","author":"Williams","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2014.06.006_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1176\/ajp.2007.164.5.753","article-title":"Acceptability of second-step treatments to depressed outpatients: a STAR*D report","volume":"164","author":"Wisniewski","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2014.06.006_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1176\/appi.ajp.2008.08071027","article-title":"Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report","volume":"166","author":"Wisniewski","year":"2009","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2014.06.006_bib37","first-page":"1896","article-title":"Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients","volume":"31","author":"Wolfe","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jad.2014.06.006_bib38","unstructured":"Yavorsky, C., Williams, J.B.W., 2009. Research assessment of depression diagnosis and severity: Comparability of telephone and in-person interview. In: Proceedings of the Poster presented at American Psychiatric Association 162nd Annual Meeting, May 20 2009 San Francisco, CA."},{"issue":"6","key":"10.1016\/j.jad.2014.06.006_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta. Psychiatr. Scand."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400367X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400367X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T06:52:46Z","timestamp":1538549566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271400367X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":39,"alternative-id":["S016503271400367X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.06.006","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}